These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 18974025

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
    Assem M, El Azab G, Rasheed MA, Abdelfatah M, Shastery M.
    Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori.
    Chuah SK, Hsu PI, Chang KC, Chiu YC, Wu KL, Chou YP, Hu ML, Tai WC, Chiu KW, Chiou SS, Wu DC, Hu TH.
    Helicobacter; 2012 Jun; 17(3):216-23. PubMed ID: 22515360
    [Abstract] [Full Text] [Related]

  • 5. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori.
    Polat Z, Kadayifci A, Kantarcioglu M, Ozcan A, Emer O, Uygun A.
    Eur J Intern Med; 2012 Mar; 23(2):165-8. PubMed ID: 22284248
    [Abstract] [Full Text] [Related]

  • 6. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L, Coraggio D, Capodicasa S, Grossi L, Cappello G.
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [Abstract] [Full Text] [Related]

  • 7. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
    Hung IF, Chan P, Leung S, Chan FS, Hsu A, But D, Seto WK, Wong SY, Chan CK, Gu Q, Tong TS, Cheung TK, Chu KM, Wong BC.
    Helicobacter; 2009 Dec; 14(6):505-11. PubMed ID: 19889067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication.
    Iacopini F, Crispino P, Paoluzi OA, Consolazio A, Pica R, Rivera M, Palladini D, Nardi F, Paoluzi P.
    Dig Liver Dis; 2005 Aug; 37(8):571-6. PubMed ID: 15996628
    [Abstract] [Full Text] [Related]

  • 10. Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China.
    Qian J, Ye F, Zhang J, Yang YM, Tu HM, Jiang Q, Shang L, Pan XL, Shi RH, Zhang GX.
    Helicobacter; 2012 Dec; 17(6):478-85. PubMed ID: 23067317
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q, Pan Y, Zhang L, Xiao SD.
    Chin J Dig Dis; 2005 Dec; 6(4):202-5. PubMed ID: 16246231
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
    Kuo CH, Hu HM, Kuo FC, Hsu PI, Chen A, Yu FJ, Tsai PY, Wu IC, Wang SW, Li CJ, Weng BC, Chang LL, Jan CM, Wang WM, Wu DC.
    J Antimicrob Chemother; 2009 May; 63(5):1017-24. PubMed ID: 19246508
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment.
    Sacco F, Spezzaferro M, Amitrano M, Grossi L, Manzoli L, Marzio L.
    Dig Liver Dis; 2010 Feb; 42(2):110-4. PubMed ID: 19846355
    [Abstract] [Full Text] [Related]

  • 15. Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
    Wang Z, Wu S.
    Singapore Med J; 2012 Apr; 53(4):273-6. PubMed ID: 22511052
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.
    Federico A, Nardone G, Gravina AG, Iovene MR, Miranda A, Compare D, Pilloni PA, Rocco A, Ricciardiello L, Marmo R, Loguercio C, Romano M.
    Gastroenterology; 2012 Jul; 143(1):55-61.e1; quize e13-4. PubMed ID: 22484118
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
    Kang JM, Kim N, Lee DH, Park YS, Kim YR, Kim JS, Jung HC, Song IS.
    Helicobacter; 2007 Dec; 12(6):623-8. PubMed ID: 18001404
    [Abstract] [Full Text] [Related]

  • 20. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS, Parlak E, Filik L, Yolcu OF, Odemiş B, Ulker A, Saşmaz N, Ozden A, Sahin B.
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.